---
title: "Advanced Enzyme Technologies Ltd (ADVENZYMES) — Share Price, Financials & Analysis"
symbol: "ADVENZYMES"
company: "Advanced Enzyme Technologies Ltd"
canonical: "https://tapetide.com/stocks/ADVENZYMES"
isin: "INE837H01020"
nse_symbol: "ADVENZYMES"
bse_code: "540025"
sector: "Healthcare"
industry: "Biotechnology"
market_cap_cr: 3352.01
generated_at: "2026-09-13T18:21:48.898Z"
---

# Advanced Enzyme Technologies Ltd (ADVENZYMES)

Canonical page: https://tapetide.com/stocks/ADVENZYMES

## Company

- **NSE Symbol:** ADVENZYMES
- **BSE Code:** 540025
- **ISIN:** INE837H01020
- **Sector:** Healthcare
- **Industry:** Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2016-08-01
- **CEO:** Mr. Beni Prasad Rauka CA
- **Employees:** 338
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** advancedenzymes.com

## About

Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.[1]

## Latest Price

- **Price:** ₹293.4
- **Change:** -9.95 (-3.28%)
- **Open:** ₹303.35
- **Day High:** ₹303.35
- **Day Low:** ₹292
- **Previous Close:** ₹303.35
- **Volume:** 216076
- **As Of:** 2026-09-11T10:21:08+00:00

## Key Fundamentals

Observed at 2026-09-11T04:34:17.526823Z.

- **Market Cap:** ₹3352.01 Cr
- **Classification:** Microcap
- **P/E (reported):** 19.8
- **P/E (TTM):** 19.8
- **EPS (TTM):** ₹14.82
- **EPS (reported):** ₹13.3
- **Book Value:** ₹145.72
- **Price to Book:** 2.08
- **Dividend Yield:** 1.76%
- **ROE:** 10.31%
- **ROCE:** 13.58%
- **Debt to Equity:** 0.02
- **Revenue (yearly):** ₹780.6 Cr
- **Net Income:** ₹173.6 Cr
- **EBITDA:** ₹263.9 Cr
- **52-Week High:** ₹419
- **52-Week Low:** ₹251.95
- **RSI (14):** 50.12

## Tapetide Score

- **Score:** 60 / 100
- **Score date:** 2026-09-04
- **Archetype:** Out of Favour
- **What it means:** Financially sound, yet the market is not rewarding it. Cases like this usually need a specific reason the pessimism is misplaced, and patience for that reason to play out.
- **Pillar profile:** Quality: Good · Valuation: Cheap · Momentum: Falling
- **Percentile:** 87.9 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 88.26 | 9% |
| growth | 42.82 | 9% |
| momentum | 30.31 | 12% |
| ownership | 49.47 | 24% |
| quality | 66 | 22% |
| valuation | 76.79 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 40.9%

### Weaknesses

- The company has delivered a poor sales growth of 8.24% over past five years.
- Company has a low return on equity of 10.3% over last 3 years.
- Promoter holding has decreased over last 3 years: -3.27%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 10.02% | 10.9% | 28.2% |
| ebitda margin growth | -9.35% | -0.41% | -7.37% | -12.84% |
| net income growth | -14.79% | 29.55% | 12% | 1% |
| revenue growth | -3.75% | 16.51% | 11% | 8% |
| roce | -10.37% | 8.47% | 1.72% | 12.88% |
| roe | -14.72% | 13.05% | 9.81% | -5.06% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 158 | 161 | 158 | 155 | 146 | 169 | 167 | 186 | 185 | 172 | 203 | 190 |
| Expenses | 107 | 107 | 102 | 103 | 104 | 114 | 122 | 129 | 124 | 123 | 140 | 139 |
| Operating Profit | 51 | 54 | 55 | 51 | 42 | 55 | 46 | 56 | 60 | 49 | 63 | 51 |
| OPM % | 32 | 33 | 35 | 33 | 29 | 33 | 27 | 30 | 33 | 29 | 31 | 27 |
| Other Income | 6 | 14 | -6 | 7 | 10 | 8 | 9 | 9 | 10 | 20 | 7 | 13 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 | 10 | 10 |
| Profit before tax | 48 | 59 | 40 | 49 | 42 | 53 | 43 | 55 | 60 | 58 | 60 | 54 |
| Tax % | 27 | 28 | 25 | 28 | 21 | 27 | 38 | 26 | 25 | 26 | 24 | 28 |
| Net Profit | 35 | 42 | 30 | 35 | 33 | 39 | 27 | 40 | 45 | 43 | 45 | 39 |
| EPS in Rs | 3.08 | 3.74 | 2.53 | 3.05 | 2.94 | 3.37 | 2.37 | 3.57 | 3.87 | 3.8 | 3.84 | 3.31 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 391 | 420 | 444 | 502 | 529 | 541 | 624 | 637 | 746 | 750 |
| Expenses | 226 | 236 | 241 | 269 | 327 | 382 | 418 | 441 | 515 | 526 |
| Operating Profit | 165 | 184 | 203 | 232 | 203 | 158 | 206 | 196 | 230 | 224 |
| OPM % | 42 | 44 | 46 | 46 | 38 | 29 | 33 | 31 | 31 | 30 |
| Other Income | 1 | 5 | 6 | 9 | 6 | 21 | 21 | 33 | 46 | 50 |
| Interest | 9 | 5 | 4 | 3 | 3 | 3 | 4 | 5 | 4 | 2 |
| Depreciation | 18 | 21 | 26 | 28 | 35 | 35 | 35 | 37 | 40 | 40 |
| Profit before tax | 139 | 162 | 179 | 210 | 171 | 140 | 188 | 187 | 233 | 231 |
| Tax % | 33 | 28 | 26 | 28 | 28 | 26 | 27 | 28 | 25 | — |
| Net Profit | 94 | 116 | 133 | 151 | 124 | 104 | 137 | 134 | 174 | 172 |
| EPS in Rs | 8.07 | 9.95 | 11.58 | 13.09 | 10.7 | 9.45 | 11.92 | 11.72 | 15.07 | 14.82 |
| Dividend Payout % | 6 | 6 | 5 | 7 | 9 | 11 | 43 | 44 | 36 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 442 | 537 | 657 | 817 | 948 | 1066 | 1213 | 1302 | 1398 | 1610 |
| Borrowings | 54 | 67 | 35 | 28 | 23 | 35 | 34 | 47 | 39 | 32 |
| Other Liabilities | 65 | 102 | 91 | 104 | 153 | 137 | 142 | 150 | 151 | 170 |
| Total Liabilities | 583 | 727 | 805 | 971 | 1146 | 1260 | 1411 | 1521 | 1611 | 1834 |
| Fixed Assets | 421 | 491 | 495 | 563 | 601 | 619 | 649 | 650 | 679 | 692 |
| CWIP | 8 | 11 | 10 | 10 | 10 | 15 | 22 | 41 | 22 | 51 |
| Investments | 0 | 0 | 111 | 124 | 121 | 102 | 360 | 403 | 480 | 584 |
| Other Assets | 153 | 226 | 188 | 275 | 413 | 524 | 380 | 427 | 430 | 507 |
| Total Assets | 583 | 727 | 805 | 971 | 1146 | 1260 | 1411 | 1521 | 1611 | 1834 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 107 | 116 | 129 | 141 | 163 | 122 | 140 | 141 | 142 | 157 |
| Cash from Investing Activity | -60 | -60 | -124 | -43 | -27 | 2 | -286 | -65 | -89 | -72 |
| Cash from Financing Activity | -65 | -2 | -43 | -39 | -26 | -48 | -26 | -59 | -73 | -70 |
| Net Cash Flow | -18 | 54 | -38 | 60 | 109 | 75 | -171 | 17 | -20 | 15 |
| Free Cash Flow | 97 | 105 | 116 | 90 | 143 | 95 | 102 | 94 | 108 | 105 |
| CFO/OP | 105 | 97 | 70 | 94 | 94 | 87 | 112 | 93 | 103 | 96 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 55 | 55 | 51 | 61 | 63 | 61 | 68 | 58 | 66 | 71 |
| Inventory Days | 352 | 339 | 363 | 361 | 346 | 402 | 343 | 375 | 378 | 335 |
| Days Payable | 57 | 78 | 46 | 43 | 56 | 60 | 67 | 40 | 47 | 76 |
| Cash Conversion Cycle | 351 | 315 | 369 | 379 | 353 | 404 | 344 | 393 | 397 | 331 |
| Working Capital Days | 76 | 47 | 72 | 90 | 94 | 116 | 109 | 102 | 112 | 116 |
| ROCE % | 31 | 25 | 24 | 22 | 22 | 16 | 12 | 15 | 13 | 14 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 45.92% | 43.62% | 43.49% | 43.02% | 42.95% | 42.93% | 43.08% | 43.08% | 43.07% | 43.04% | 43.26% | 43.24% |
| FIIs | 22.27% | 22.54% | 23.01% | 12.03% | 12.63% | 12.58% | 11.9% | 23.46% | 25.41% | 25.86% | 25.49% | 26.71% |
| DIIs | 5.84% | 5.42% | 7.56% | 8.08% | 8.02% | 8.18% | 8.19% | 8.45% | 6.41% | 5.51% | 5.41% | 4.78% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 15.28% | 15.9% | 15.43% | 16.42% | 16.04% | 16.11% | 16.68% | 16.92% | 16.95% | 17.44% | 17.57% | 16.94% |
| Others | 10.7% | 12.52% | 10.51% | 20.45% | 20.36% | 20.21% | 20.16% | 8.1% | 8.15% | 8.15% | 8.26% | 8.33% |
| No. of Shareholders | 72642 | 73034 | 68640 | 65222 | 66758 | 67351 | 65322 | 67589 | 69637 | 68051 | 66193 | 63599 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 6 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 296.45 | Sell |
| EMA (10) | 297.79 | Sell |
| SMA (20) | 298.9 | Sell |
| EMA (20) | 300.11 | Sell |
| SMA (50) | 310 | Sell |
| EMA (50) | 310.42 | Sell |
| SMA (100) | 334.24 | Sell |
| EMA (100) | 317.39 | Sell |
| SMA (200) | 314.31 | Sell |
| EMA (200) | 317.16 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 40.68 | Neutral |
| MACD (12,26,9) | -4.1 | Buy |
| Stochastic (14,3,3) | 39.62 | Neutral |
| ADX (14) | 12.21 | Neutral |
| Williams %R (14) | -90.26 | Buy |
| ATR (14) | 8.83 | High Volatility |
| ROC (12) | -1.28 | Sell |
| Stoch RSI (14) | 31.45 | Neutral |
| UO (7,14,28) | 38.12 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 1 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |

Based on 1 analyst ratings, observed at 2026-09-11T04:34:18.946353+00:00.

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - Dipak Roda resigns as Senior VP, effective April 9, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 9 Apr - Dipak Roda resigns as Senior VP, effective April 9, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d2ec59d2-f65e-4014-80fc-af19de69c177.pdf) |
| 7 Feb - Transcript of the earnings call held on February 04, 2026. | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 7 Feb - Transcript of the earnings call held on February 04, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/180ea216-6a53-4636-ab60-29dd53fac631.pdf) |
| 5 May - The Company will host a Conference call for Analysts and Investors to discuss the financial results of the Company for the quarter and year ended … | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 5 May - The Company will host a Conference call for Analysts and Investors to discuss the financial results of the Company for the quarter and year ended …](https://www.bseindia.com/xml-data/corpfiling/AttachLive/3de44f22-8b7c-4194-ad08-ba9238006df7.pdf) |
| 4 Feb - Audio recording of Feb 4, 2026 conference call on quarter and nine-months ended Dec 31, 2025; transcript forthcoming. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 4 Feb - Audio recording of Feb 4, 2026 conference call on quarter and nine-months ended Dec 31, 2025; transcript forthcoming.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fcea7cd5-3b2f-4b34-b2c9-8f7821638d4b.pdf) |
| 2d - FY26 audited results approved; final dividend ₹1.35/share, director appointments, and 49,350 ESOP shares allotted. | [Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s 2d - FY26 audited results approved; final dividend ₹1.35/share, director appointments, and 49,350 ESOP shares allotted.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/bdac7060-4885-4e55-aae4-0083c152b754.pdf) |
| 2d - Earnings Presentation for the Quarter and Year ended March 31, 2026 | [Announcement under Regulation 30 (LODR)-Investor Presentation 2d - Earnings Presentation for the Quarter and Year ended March 31, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0276b659-a9b1-4b22-8c8b-e6abf442e7e4.pdf) |
| 2d - CRISIL reaffirmed A+/Stable and A1+ ratings for ₹100 crore bank facilities. | [Announcement under Regulation 30 (LODR)-Credit Rating 2d - CRISIL reaffirmed A+/Stable and A1+ ratings for ₹100 crore bank facilities.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/365639ee-c870-40a6-8c96-512b05b7e084.pdf) |
| 2d - Allotment of 49,350 Equity Shares of face value of Rs. 2/- per share pursuant to the Exercise of Options under Advanced Enzyme Technologies Limited - … | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 2d - Allotment of 49,350 Equity Shares of face value of Rs. 2/- per share pursuant to the Exercise of Options under Advanced Enzyme Technologies Limited - …](https://www.bseindia.com/xml-data/corpfiling/AttachLive/81737a25-8bf0-4039-afd9-82a749e30de2.pdf) |
| 2d - Advanced Enzyme announced Q4 FY26 and FY26 results; revenue rose 17%, PAT 30%, call on May 12. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 2d - Advanced Enzyme announced Q4 FY26 and FY26 results; revenue rose 17%, PAT 30%, call on May 12.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/23255349-5842-4713-b22b-6d550fec95e3.pdf) |
| 2 May - Board meets May 9, 2026 to approve FY26 results and consider final or interim dividend; trading window closes till May 11. | [Board Meeting Intimation for Q4 Of FY 2026 2 May - Board meets May 9, 2026 to approve FY26 results and consider final or interim dividend; trading window closes till May 11.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8ffad007-fc76-4276-a9a8-e9a5d4dbf54a.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-10 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06dd5112-0e94-4866-903b-047b916f600c.pdf) |
| 2026-09-10 | [Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c82fa22-09d2-4b56-819f-8f1228ebf1af.pdf) |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff5a892f-6870-4e1c-beff-2fb01be3a951.pdf) |
| 2026-09-08 | [Corporate Action-Updates on Buy back](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=241c4ea1-d82e-45bc-83c3-a6c7c9a20aa0.pdf) |
| 2026-09-08 | [Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83bf792b-306a-4f17-bd1a-821c83484cdb.pdf) |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a84777ef-48a9-4322-a6f2-bb3d42ce9554.pdf) |
| 2026-09-05 | [Disclosure Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (As Amended)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd5cd1b4-3e93-4103-bd51-dea313fa8c52.pdf) |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19458c13-5906-4faf-8816-e6edd364be9c.pdf) |
| 2026-09-03 | [Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80fbfc57-1261-4f6e-85c2-a13ec353b719.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea11cbc3-7163-47ea-9381-91f45dda8290.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-18 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a02c4f0-6b61-41bc-9730-08a3360dfa9d.pdf) |
| 2026-05-15 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a2a6a79-daf4-4bc1-b2c3-11532ef8b843.pdf) |
| 2026-02-07 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=180ea216-6a53-4636-ab60-29dd53fac631.pdf) |
| 2025-11-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98f9af2e-9e6f-4756-89f4-1de7b2a1585d.pdf) |
| 2025-08-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=791b6684-0467-4aec-b40f-d153e38e279c.pdf) |
| 2025-05-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4560608f-45b8-45c5-8573-e1c4c965cc63.pdf) |
| 2025-02-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e589c260-74b6-4f8c-b2a8-59f244d6646c.pdf) |
| 2024-11-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c75e7ab-ee58-4811-91a5-b4cc0acadff5.pdf) |
| 2024-05-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bbd7851-d460-4af9-ab19-5fbc14c339e9.pdf) |
| 2024-02-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=addcd500-fbd6-48cb-b321-cd591ff15a4d.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec744fd5-5d5a-4771-b598-eab1750b29b6.pdf) |
| 2026-05-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eacb319d-397b-4331-ac5b-b9dad2298156.pdf) |
| 2026-02-04 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcea7cd5-3b2f-4b34-b2c9-8f7821638d4b.pdf) |
| 2025-11-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0cf7c856-3d15-451c-8433-40dd82060157.pdf) |
| 2025-08-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0488ec55-2e27-4e3a-b106-488ff695c9b6.pdf) |
| 2025-05-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83ae2855-c1e8-4d68-aad5-b51a73ec0127.pdf) |
| 2024-11-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1b22f0e-ba0e-40f1-8895-f005c09b8a23.pdf) |
| 2024-08-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=645fbac8-22b4-40ff-b79f-a4929fc9d54b.pdf) |
| 2024-05-15 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b83305e5-7df2-46ca-b2f4-99f1679e391a.pdf) |
| 2024-02-16 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02db4abf-a3db-4e9f-8b44-80d557cefae4.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-08 | [Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=926e66db-7763-4878-ac03-cc5c254f56c4.pdf) |
| 2026-05-09 | [Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11f1a7e6-94d3-4350-87ff-83885eff3788.pdf) |
| 2026-01-31 | [Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaf65f4e-7c7e-46c8-93e6-b8ad49eb3969.pdf) |
| 2025-11-12 | [Standalone And Consolidated Financial Results For Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4de6c86b-6731-490d-9bb2-1d0812ee0915.pdf) |
| 2025-08-02 | [Unaudited Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9520edd-4fae-403e-bc54-86b5396d6ea1.pdf) |
| 2025-05-13 | [Standalone And Consolidated Results For FY 2024-25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e957cb9-46d1-447d-be2b-5079dcf90b37.pdf) |
| 2025-02-08 | [Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64cda602-363d-4682-8a8a-55df1f381f4f.pdf) |
| 2024-11-09 | [Board Meeting Outcome for Outcome Of Board Meeting Held On November 09, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a1e0922-6e89-4910-bc42-d9d726acb56b.pdf) |
| 2024-11-09 | [Outcome Of Board Meeting Held On November 09, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d54dbb2-3984-41df-919c-409a123ee6b5.pdf) |
| 2024-08-10 | [Statement Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5058de09-a7cc-4b2d-9e07-6b309a32aadd.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6da558b-2e17-483e-be88-63b60c5f6a6a.pdf) |
| 2026-05-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0276b659-a9b1-4b22-8c8b-e6abf442e7e4.pdf) |
| 2026-01-31 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c354304-ec2f-4ebe-82ed-74a8a9f086c1.pdf) |
| 2025-11-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cddf073-491e-4bdf-907a-5c5e21684dee.pdf) |
| 2025-09-22 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62c3a31a-e1de-4aa3-863b-d598a0d55844.pdf) |
| 2025-08-02 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6926ddae-87f0-461d-84f9-b39a39161b6d.pdf) |
| 2025-05-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=711f2bd9-953a-4024-8e43-5c987169e560.pdf) |
| 2025-02-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ceeeff9-94ba-48db-8f39-70eb44eb95a6.pdf) |
| 2024-11-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3a15dbe-f8b6-498a-84dd-51d08b919e78.pdf) |
| 2024-08-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2d34c4f-043b-42f5-a280-f5e4bcbe329f.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2025 | [Concall - Sep 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/62c3a31a-e1de-4aa3-863b-d598a0d55844.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/98f9af2e-9e6f-4756-89f4-1de7b2a1585d.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3c75e7ab-ee58-4811-91a5-b4cc0acadff5.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6d03babb-435b-46dc-8361-9e3c8557dbd3.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5cec976a-063d-4d29-b2b9-f549a09a8a57.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6a2a6a79-daf4-4bc1-b2c3-11532ef8b843.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/6a2a6a79-daf4-4bc1-b2c3-11532ef8b843.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0276b659-a9b1-4b22-8c8b-e6abf442e7e4.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4560608f-45b8-45c5-8573-e1c4c965cc63.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7bbd7851-d460-4af9-ab19-5fbc14c339e9.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5462d81d-d4ba-44f3-9286-e5e4e930414c.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/12471189-42b0-4377-9210-a04def767ceb.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f7577ee1-5170-4194-9213-a5fe787d1a43.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/95e0d661-fab4-4b3c-a785-976cda20a2dd.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:21:48.898Z.